| Print
Annovis Bio (ANVS)
Ordinary SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Annovis Bio Inc Third Quarter Earnings Results for 2026 | 2026-11-12T00:00:00 |
| Annovis Bio Inc Second Quarter Earnings Results for 2026 | 2026-08-12T00:00:00 |
| Annovis Bio Inc Annual General Meeting for 2026 | 2026-06-17T10:00:00 |
| Annovis Bio Inc First Quarter Earnings Results for 2026 | 2026-05-13T00:00:00 |
| Annovis Bio Inc Fourth Quarter Earnings Results for 2025 | 2026-03-20T00:00:00 |
| Annovis Bio Inc Annual Report for 2025 | 2026-03-20T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Annovis Bio Inc Third Quarter Earnings Results for 2025 | 2025-11-12T00:00:00 |
| H.C. Wainwright 27th Annual Global Investment Conference 2025 | 2025-09-10T12:00:00 |
| Annovis Bio Inc Second Quarter Earnings Results for 2025 | 2025-08-12T00:00:00 |
| Annovis Bio Inc Annual General Meeting for 2025 | 2025-06-17T10:00:00 |
| Annovis Bio Inc First Quarter Earnings Results for 2025 | 2025-05-13T00:00:00 |
| Annovis Bio Inc Fourth Quarter Earnings Results for 2024 | 2025-03-21T00:00:00 |
| Annovis Bio Inc Annual Report for 2024 | 2025-03-21T00:00:00 |
| Oppenheimer's 35th Annual Healthcare Life Sciences Conference | 2025-02-11T12:40:00 |
| Annovis to Host Year-End Investor Webcast 2024 | 2024-12-11T16:30:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.